社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Propanc Biopharma, Inc.(PPCB)
盘后
1.44
0.00
0.00%
19:50 EDT
1.44
-0.06
-4.00%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
capt
·
06-11
$Propanc Biopharma, Inc.(PPCB)$
[财迷]
$Propanc Biopharma, Inc.(PPCB)$ [财迷]
回复
评论
点赞
1
编组 21备份 2
分享
举报
比钻石还光亮
·
2025-08-20
$Propanc Biopharma, Inc.(PPCB)$
星期一来 星期三又来 真牛逼了
$Propanc Biopharma, Inc.(PPCB)$ 星期一来 星期三又来 真牛逼了
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
小虎周报
·
2025-08-18
一周IPO观察:中慧生物/银诺医药大涨,双登股份招股,奥克斯过讯,Bullish美股上市,Gemini递表
港股IPO观察截止2025年的第33周,港交所2家上市,1家招股,3家聆讯,8家递表。当周上市(2家)研发流感疫苗的生物医药公司
$中慧生物-B(02627)$
糖尿病等代谢性疾病创新疗法的生物医药公司
$银诺医药-B(02591)$
当周招股(1家)(A+H)全球碳化硅衬底龙头公司
$天岳先进(02631)$
(8月11日)通过聆讯(3家)数据中心绿电+储能电池厂商
$双登股份(06960)$
哈萨克斯坦钨矿公司$佳鑫国际全球前五大空调提供商之一奥克斯递表公司(8家)纸尿裤等婴儿及女性卫生用品的供应商乐舒适(A+H)防爆电驱系统解决方案提供商
$卧龙电驱(600580)$
(A+H)废物综合处理及资源利用专业解决方案
$军信股份(301109)$
消费级3D打印产品及服务提供商创想三维中国第三大手机回收服务提供商闪回科技伤口愈合的蛋白质药物的创新生物医药公司华芢生物新兴的母婴产品供应商不同集团中国最大型的儿童及青少年艺术培训机构卓优智美上周个股表现两家18A中慧生物-B、银诺医药-B正式上市,首日表现相当亮眼,分别涨157.98%、206.48%,且分别是新规前最后一只以及新规后的首只。其中银诺医药公司选择了机制B(公开比例固定),比例为10%,因此公开市场散户更难中签。双登集团、佳鑫
一周IPO观察:中慧生物/银诺医药大涨,双登股份招股,奥克斯过讯,Bullish美股上市,Gemini递表
回复
评论
点赞
6
编组 21备份 2
分享
举报
小虎周报
·
2025-08-04
一周IPO观察:中慧生物超购过千倍,Figma首日暴涨250%
港股IPO观察截止2025年的第31周,港交所无新股上市,没有上市,1家招股,3家聆讯,7家递表。当周上市(无)当周招股(1家)研发流感疫苗的生物医药公司
$中慧生物-B(02627)$
通过聆讯(3家)(A+H)全球碳化硅衬底龙头公司
$天岳先进(688234)$
糖尿病等代谢性疾病创新疗法的生物医药公司$银诺医药-B递表公司(7家)香港保健及美容补充品与产品的开发、销售、营销及分销公司正品控股中医医疗服务提供商问止中医科技(A+H)全球最大手机电池厂商
$欣旺达(300207)$
(A+H)AI芯片龙头公司
$云天励飞(688343)$
细菌感染及细菌代谢想关疾病领域的生物科技公司丹诺医药病毒感染、神经精神及生殖健康生物医药研发公司旺山旺水铝产业链上游中的氧化铝精炼和电解铝冶炼公司创新国际其他空调制造商奥克斯电气(Aux Electric Co.)计划最早于9月到香港上市,拟集资6亿至8亿美元(折合约47亿至62.8亿港元)
$中国儒意(00136)$
拟配股融资39亿,无极资本拟以每股认购价3.00港元认购,募资39亿港元上周个股表现中慧生物-B开启招股招股结束并于8月5日结束,其核心产品今年1月获批,至8月4日,孖展认购倍数已超1000倍。有7家公司递表,包括正品控股、问止中医、欣旺达、云天励飞、丹诺医药、旺山旺水、创新国际,其中欣旺达和云天励飞都是A+H。
一周IPO观察:中慧生物超购过千倍,Figma首日暴涨250%
回复
1
点赞
4
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
Propanc Biopharma, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.propanc.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Propanc Biopharma, Inc.最初于2007年10月15日在澳大利亚维多利亚州墨尔本成立。2010年11月23日,该公司在特拉华州重新注册并重新注册。他们是一家发展阶段的医疗保健公司,目前专注于为患有胰腺癌、卵巢癌和癌症的患者开发新的癌症治疗方法。利用他们的科学和肿瘤学顾问,他们开发了一种合理的抗癌化合物复合配方,这些化合物共同发挥多种作用,旨在控制或防止肿瘤在体内复发和扩散。他们的主要候选产品PRP是他们新配方的变体,涉及酶原,即酶的无活性前体。
05-14
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04-16
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
04-10
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
02-26
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-20
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
02-19
[修订]招股说明书
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
02-17
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02-13
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
02-11
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
02-02
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
01-07
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-30
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-11-14
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-10
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-10-14
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
分时
5日
日
周
月
数据加载中...
最高
1.56
今开
1.56
量比
0.34
最低
1.41
昨收
1.50
换手率
17.17%
热议股票
{"pagemeta":{"title":"Propanc Biopharma, Inc.(PPCB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Propanc Biopharma, Inc.(PPCB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Propanc Biopharma, Inc.,PPCB,Propanc Biopharma, Inc.股票,Propanc Biopharma, Inc.股票老虎,Propanc Biopharma, Inc.股票老虎国际,Propanc Biopharma, Inc.行情,Propanc Biopharma, Inc.股票行情,Propanc Biopharma, Inc.股价,Propanc Biopharma, Inc.股市,Propanc Biopharma, Inc.股票价格,Propanc Biopharma, Inc.股票交易,Propanc Biopharma, Inc.股票购买,Propanc Biopharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Propanc Biopharma, Inc.(PPCB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Propanc Biopharma, Inc.(PPCB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"PPCB","data":{"stockData":{"symbol":"PPCB","market":"US","secType":"STK","nameCN":"Propanc Biopharma, Inc.","latestPrice":1.44,"timestamp":1782936000000,"preClose":1.5,"halted":0,"volume":46239,"hourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.44,"latestTime":"19:50 EDT","volume":476,"amount":680.6403,"timestamp":1782949803937,"change":0,"changeRate":0,"amplitude":0.019375},"delay":0,"changeRate":-0.040000000000000036,"floatShares":269356,"shares":2278372,"eps":-32.455997,"marketStatus":"未开盘","change":-0.06,"latestTime":"07-01 16:00:00 EDT","open":1.56,"high":1.56,"low":1.41,"amount":67671.9278511,"amplitude":0.1,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-32.455997,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1782979200000},"marketStatusCode":0,"adr":0,"listingDate":1743998400000,"exchange":"NASDAQ","adjPreClose":1.5,"preHourTrading":{"tag":"盘前","latestPrice":1.5,"preClose":1.5,"latestTime":"09:22 EDT","volume":860,"amount":1304.8505659999998,"timestamp":1782912125444,"change":0,"changeRate":0,"amplitude":0.06},"postHourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.44,"latestTime":"19:50 EDT","volume":476,"amount":680.6403,"timestamp":1782949803937,"change":0,"changeRate":0,"amplitude":0.019375},"volumeRatio":0.342783},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.574151225696800","cardData":[{"tweetId":"574151225696800","author":{"authorId":"3446725718659410","idStr":"3446725718659410","name":"capt","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/PPCB\">$Propanc Biopharma, Inc.(PPCB)$ </a> [财迷] ","plainDigest":"$Propanc Biopharma, Inc.(PPCB)$ [财迷]","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1781187516193,"gmtModify":1781188345427,"symbols":["PPCB"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":446,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/574151225696800","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":35,"displayRows":4,"foldSize":0,"authorId":"3446725718659410"}]},{"cardType":"TWEET","cardId":"TWEET.469597470314560","cardData":[{"tweetId":"469597470314560","author":{"authorId":"3445990815937032","idStr":"3445990815937032","name":"比钻石还光亮","avatar":"https://static.tigerbbs.com/2e627dcadce8728caf95df996b2c17fb","userType":1,"introduction":"","crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":201,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/PPCB\">$Propanc Biopharma, Inc.(PPCB)$ </a> 星期一来 星期三又来 真牛逼了","plainDigest":"$Propanc Biopharma, Inc.(PPCB)$ 星期一来 星期三又来 真牛逼了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1755679372655,"gmtModify":1755679957806,"symbols":["PPCB"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":845,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/469597470314560","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":55,"displayRows":4,"foldSize":0,"authorId":"3445990815937032"}]},{"cardType":"TWEET","cardId":"TWEET.468858086068416","cardData":[{"tweetId":"468858086068416","author":{"authorId":"36979109942400","idStr":"36979109942400","name":"小虎周报","avatar":"https://static.laohu8.com/f7b172cf773c77a3f0df67695c126b51","userType":4,"introduction":"老虎股票官方帐号","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"一周IPO观察:中慧生物/银诺医药大涨,双登股份招股,奥克斯过讯,Bullish美股上市,Gemini递表","digest":"港股IPO观察截止2025年的第33周,港交所2家上市,1家招股,3家聆讯,8家递表。当周上市(2家)研发流感疫苗的生物医药公司 <a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$</a> 糖尿病等代谢性疾病创新疗法的生物医药公司 <a href=\"https://laohu8.com/S/02591\">$银诺医药-B(02591)$</a> 当周招股(1家)(A+H)全球碳化硅衬底龙头公司 <a href=\"https://laohu8.com/S/02631\">$天岳先进(02631)$</a> (8月11日)通过聆讯(3家)数据中心绿电+储能电池厂商 <a href=\"https://laohu8.com/S/06960\">$双登股份(06960)$</a> 哈萨克斯坦钨矿公司$佳鑫国际全球前五大空调提供商之一奥克斯递表公司(8家)纸尿裤等婴儿及女性卫生用品的供应商乐舒适(A+H)防爆电驱系统解决方案提供商 <a href=\"https://laohu8.com/S/600580\">$卧龙电驱(600580)$</a> (A+H)废物综合处理及资源利用专业解决方案 <a href=\"https://laohu8.com/S/301109\">$军信股份(301109)$</a> 消费级3D打印产品及服务提供商创想三维中国第三大手机回收服务提供商闪回科技伤口愈合的蛋白质药物的创新生物医药公司华芢生物新兴的母婴产品供应商不同集团中国最大型的儿童及青少年艺术培训机构卓优智美上周个股表现两家18A中慧生物-B、银诺医药-B正式上市,首日表现相当亮眼,分别涨157.98%、206.48%,且分别是新规前最后一只以及新规后的首只。其中银诺医药公司选择了机制B(公开比例固定),比例为10%,因此公开市场散户更难中签。双登集团、佳鑫","plainDigest":"港股IPO观察截止2025年的第33周,港交所2家上市,1家招股,3家聆讯,8家递表。当周上市(2家)研发流感疫苗的生物医药公司 $中慧生物-B(02627)$ 糖尿病等代谢性疾病创新疗法的生物医药公司 $银诺医药-B(02591)$ 当周招股(1家)(A+H)全球碳化硅衬底龙头公司 $天岳先进(02631)$ (8月11日)通过聆讯(3家)数据中心绿电+储能电池厂商 $双登股份(06960)$ 哈萨克斯坦钨矿公司$佳鑫国际全球前五大空调提供商之一奥克斯递表公司(8家)纸尿裤等婴儿及女性卫生用品的供应商乐舒适(A+H)防爆电驱系统解决方案提供商 $卧龙电驱(600580)$ (A+H)废物综合处理及资源利用专业解决方案 $军信股份(301109)$ 消费级3D打印产品及服务提供商创想三维中国第三大手机回收服务提供商闪回科技伤口愈合的蛋白质药物的创新生物医药公司华芢生物新兴的母婴产品供应商不同集团中国最大型的儿童及青少年艺术培训机构卓优智美上周个股表现两家18A中慧生物-B、银诺医药-B正式上市,首日表现相当亮眼,分别涨157.98%、206.48%,且分别是新规前最后一只以及新规后的首只。其中银诺医药公司选择了机制B(公开比例固定),比例为10%,因此公开市场散户更难中签。双登集团、佳鑫","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1755489739986,"gmtModify":1755499189811,"symbols":["NUTR","BLSH","02627","301109","RYOJ","02631","BUUU","NSRX","02591","06960","600580","MIAX","MAGH","PPCB"],"themeIds":["8615a5978dcb4976a0dd96cdbca43719","0e78c0db8cb445f7b26f2b55e79c0399","c84bf6b420c54df386ed96129eb27e88"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/64d2f83880d378540edc48d7d0e62072"}],"repostCount":2,"viewCount":28637,"likeCount":6,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":true,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/468858086068416","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":true,"upFlag":false,"length":7421,"displayRows":4,"foldSize":0,"authorId":"36979109942400"}]},{"cardType":"TWEET","cardId":"TWEET.463905148170360","cardData":[{"tweetId":"463905148170360","author":{"authorId":"36979109942400","idStr":"36979109942400","name":"小虎周报","avatar":"https://static.laohu8.com/f7b172cf773c77a3f0df67695c126b51","userType":4,"introduction":"老虎股票官方帐号","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"一周IPO观察:中慧生物超购过千倍,Figma首日暴涨250%","digest":"港股IPO观察截止2025年的第31周,港交所无新股上市,没有上市,1家招股,3家聆讯,7家递表。当周上市(无)当周招股(1家)研发流感疫苗的生物医药公司 <a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$</a> 通过聆讯(3家)(A+H)全球碳化硅衬底龙头公司 <a href=\"https://laohu8.com/S/688234\">$天岳先进(688234)$</a> 糖尿病等代谢性疾病创新疗法的生物医药公司$银诺医药-B递表公司(7家)香港保健及美容补充品与产品的开发、销售、营销及分销公司正品控股中医医疗服务提供商问止中医科技(A+H)全球最大手机电池厂商 <a href=\"https://laohu8.com/S/300207\">$欣旺达(300207)$</a> (A+H)AI芯片龙头公司 <a href=\"https://laohu8.com/S/688343\">$云天励飞(688343)$</a> 细菌感染及细菌代谢想关疾病领域的生物科技公司丹诺医药病毒感染、神经精神及生殖健康生物医药研发公司旺山旺水铝产业链上游中的氧化铝精炼和电解铝冶炼公司创新国际其他空调制造商奥克斯电气(Aux Electric Co.)计划最早于9月到香港上市,拟集资6亿至8亿美元(折合约47亿至62.8亿港元) <a href=\"https://laohu8.com/S/00136\">$中国儒意(00136)$</a> 拟配股融资39亿,无极资本拟以每股认购价3.00港元认购,募资39亿港元上周个股表现中慧生物-B开启招股招股结束并于8月5日结束,其核心产品今年1月获批,至8月4日,孖展认购倍数已超1000倍。有7家公司递表,包括正品控股、问止中医、欣旺达、云天励飞、丹诺医药、旺山旺水、创新国际,其中欣旺达和云天励飞都是A+H。","plainDigest":"港股IPO观察截止2025年的第31周,港交所无新股上市,没有上市,1家招股,3家聆讯,7家递表。当周上市(无)当周招股(1家)研发流感疫苗的生物医药公司 $中慧生物-B(02627)$ 通过聆讯(3家)(A+H)全球碳化硅衬底龙头公司 $天岳先进(688234)$ 糖尿病等代谢性疾病创新疗法的生物医药公司$银诺医药-B递表公司(7家)香港保健及美容补充品与产品的开发、销售、营销及分销公司正品控股中医医疗服务提供商问止中医科技(A+H)全球最大手机电池厂商 $欣旺达(300207)$ (A+H)AI芯片龙头公司 $云天励飞(688343)$ 细菌感染及细菌代谢想关疾病领域的生物科技公司丹诺医药病毒感染、神经精神及生殖健康生物医药研发公司旺山旺水铝产业链上游中的氧化铝精炼和电解铝冶炼公司创新国际其他空调制造商奥克斯电气(Aux Electric Co.)计划最早于9月到香港上市,拟集资6亿至8亿美元(折合约47亿至62.8亿港元) $中国儒意(00136)$ 拟配股融资39亿,无极资本拟以每股认购价3.00港元认购,募资39亿港元上周个股表现中慧生物-B开启招股招股结束并于8月5日结束,其核心产品今年1月获批,至8月4日,孖展认购倍数已超1000倍。有7家公司递表,包括正品控股、问止中医、欣旺达、云天励飞、丹诺医药、旺山旺水、创新国际,其中欣旺达和云天励飞都是A+H。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1754278500216,"gmtModify":1754278978799,"symbols":["FIG","02627","AMBQ","300207","688234","00136","PMI","WYFI","BUUU","688343","YMAT","HTFL","DXG","FLY","SI","PPCB"],"themeIds":["d8583e220f5a439fac865ccf50d75143","0e78c0db8cb445f7b26f2b55e79c0399","c84bf6b420c54df386ed96129eb27e88"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/64d2f83880d378540edc48d7d0e62072"}],"repostCount":1,"viewCount":33654,"likeCount":4,"liked":false,"collected":false,"commentCount":1,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":true,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/463905148170360","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":true,"upFlag":false,"length":6165,"displayRows":4,"foldSize":0,"authorId":"36979109942400"}]}],"size":4},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"21261022","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226023210-PPCB","pdf_url":"","pub_time":1778731200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"PPCB","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226023210/0001493152-26-023210-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226023210/form10-q.htm","primary":true,"translateUrl":"","linkName":"form10-q.htm","type":"10-Q","id":"NTFILEGymgMiu7YSJm2UbP","market":"us","size":2572804},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226023210/ex31-1.htm","primary":false,"translateUrl":"","linkName":"ex31-1.htm","type":"EX-31.1","id":"NTFILE7WnWuJT9q296GH7b","market":"us","size":31821},{"description":"EX-32.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226023210/ex32-1.htm","primary":false,"translateUrl":"","linkName":"ex32-1.htm","type":"EX-32.1","id":"NTFILE9hDEwzmN5MUrdXGd","market":"us","size":13936}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2026-05-14 12:00","pubTimestamp":1778731200,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21313588","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226017000-PPCB","pdf_url":"","pub_time":1776353422000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"PPCB","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1517681/0001493152-26-017000-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226017000/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILECvQX1JJfTpCkBjUd","market":"us","size":9913}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2026-04-16 23:30","pubTimestamp":1776353422,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20988510","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226016228-PPCB","pdf_url":"","pub_time":1775793600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"PPCB","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226016228/0001493152-26-016228-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226016228/forms-1.htm","primary":true,"translateUrl":"","linkName":"forms-1.htm","type":"S-1","id":"NTFILEATks2DnFFJy4bgWt","market":"us","size":5640321},{"description":"EX-5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226016228/ex5-1.htm","primary":false,"translateUrl":"","linkName":"ex5-1.htm","type":"EX-5.1","id":"NTFILE6RH6w3KUgrGhgKaa","market":"us","size":21984},{"description":"EX-23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226016228/ex23-1.htm","primary":false,"translateUrl":"","linkName":"ex23-1.htm","type":"EX-23.1","id":"NTFILEG6CqT7RrahVGPhrr","market":"us","size":4284},{"description":"EX-FILING FEES","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226016228/ex107.htm","primary":false,"translateUrl":"","linkName":"ex107.htm","type":"EX-FILING FEES","id":"NTFILE8HcDvRRKzLhhgmWU","market":"us","size":24483},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226016228/forms-1_001.jpg","primary":false,"translateUrl":"","linkName":"forms-1_001.jpg","type":"GRAPHIC","id":"NTFILE6deVNbCg616d3Cxr","market":"us","size":27451},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226016228/audit_001.jpg","primary":false,"translateUrl":"","linkName":"audit_001.jpg","type":"GRAPHIC","id":"NTFILE3WhmzaZh2V3Qri86","market":"us","size":30513},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226016228/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILExoWpw1SwF9h7PAx2","market":"us","size":5706}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2026-04-10 12:00","pubTimestamp":1775793600,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20771555","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226008196-PPCB","pdf_url":"","pub_time":1772082000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"PPCB","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226008196/0001493152-26-008196-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-10.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226008196/ex10-1.htm","primary":true,"translateUrl":"","linkName":"ex10-1.htm","type":"EX-10.1","id":"NTFILE7XNqy2oPdPS7ChKr","market":"us","size":109685},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226008196/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILE7DrqY1sy1DUY2ot2","market":"us","size":37836}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-26 13:00","pubTimestamp":1772082000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.02项:董事或某些高级职员的离职;选举董事;若干人员的委任:若干人员的补偿安排;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21325255","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226007520-PPCB","pdf_url":"","pub_time":1771585445000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"PPCB","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1517681/0001493152-26-007520-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007520/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEA1UEMuqDmEydWUtb","market":"us","size":10046}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2026-02-20 19:04","pubTimestamp":1771585445,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20751021","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226007492-PPCB","pdf_url":"","pub_time":1771477200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"PPCB","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007492/0001493152-26-007492-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007492/forms-1a.htm","primary":true,"translateUrl":"","linkName":"forms-1a.htm","type":"S-1/A","id":"NTFILEEdmo2qW3bK4Vu7R8","market":"us","size":5644943},{"description":"EX-5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007492/ex5-1.htm","primary":false,"translateUrl":"","linkName":"ex5-1.htm","type":"EX-5.1","id":"NTFILEGaDpFq2DwdjWwFqC","market":"us","size":21908},{"description":"EX-23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007492/ex23-1.htm","primary":false,"translateUrl":"","linkName":"ex23-1.htm","type":"EX-23.1","id":"NTFILE7icCcvs3aErnJBeu","market":"us","size":4222},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007492/forms-1_001.jpg","primary":false,"translateUrl":"","linkName":"forms-1_001.jpg","type":"GRAPHIC","id":"NTFILEALTPE4tc7XcucyRp","market":"us","size":27451},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007492/audit_001.jpg","primary":false,"translateUrl":"","linkName":"audit_001.jpg","type":"GRAPHIC","id":"NTFILE2xdrhXQDZxUUsEDc","market":"us","size":30513},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007492/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEFfoMiznLc8VTEyRC","market":"us","size":5706}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2026-02-19 13:00","pubTimestamp":1771477200,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20741630","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226007052-PPCB","pdf_url":"","pub_time":1771304400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"PPCB","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007052/0001493152-26-007052-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007052/form10-q.htm","primary":true,"translateUrl":"","linkName":"form10-q.htm","type":"10-Q","id":"NTFILE3n25FCqmwAkagWbn","market":"us","size":2152523},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007052/ex31-1.htm","primary":false,"translateUrl":"","linkName":"ex31-1.htm","type":"EX-31.1","id":"NTFILE9WdtHgahwCFbVbKm","market":"us","size":30762},{"description":"EX-32.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226007052/ex32-1.htm","primary":false,"translateUrl":"","linkName":"ex32-1.htm","type":"EX-32.1","id":"NTFILEHma98gp4wWMuiV48","market":"us","size":13589}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2026-02-17 13:00","pubTimestamp":1771304400,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21325097","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226006497-PPCB","pdf_url":"","pub_time":1770942516000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"PPCB","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1517681/0001493152-26-006497-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226006497/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEEpGk6Fx53usaQnUS","market":"us","size":8766}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2026-02-13 08:28","pubTimestamp":1770942516,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21325094","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226006023-PPCB","pdf_url":"","pub_time":1770767045000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"PPCB","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1517681/0001493152-26-006023-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226006023/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILECrKZnBmgSs4BYKCN","market":"us","size":10184}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2026-02-11 07:44","pubTimestamp":1770767045,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20689755","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226004792-PPCB","pdf_url":"","pub_time":1770008400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"PPCB","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226004792/0001493152-26-004792-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226004792/forms-1.htm","primary":true,"translateUrl":"","linkName":"forms-1.htm","type":"S-1","id":"NTFILEEiqSe7g9hBrYYBjn","market":"us","size":5067743},{"description":"EX-5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226004792/ex5-1.htm","primary":false,"translateUrl":"","linkName":"ex5-1.htm","type":"EX-5.1","id":"NTFILEgvF76ntoqHDRKXrT","market":"us","size":21576},{"description":"EX-23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226004792/ex23-1.htm","primary":false,"translateUrl":"","linkName":"ex23-1.htm","type":"EX-23.1","id":"NTFILEHDmVwEGZi5xJyUFp","market":"us","size":4205},{"description":"EX-FILING FEES","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226004792/ex107.htm","primary":false,"translateUrl":"","linkName":"ex107.htm","type":"EX-FILING FEES","id":"NTFILE92Znerv5HRsePAxs","market":"us","size":28089},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226004792/forms-1_001.jpg","primary":false,"translateUrl":"","linkName":"forms-1_001.jpg","type":"GRAPHIC","id":"NTFILE91zA9UiRGmgGDdZR","market":"us","size":27451},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226004792/audit_001.jpg","primary":false,"translateUrl":"","linkName":"audit_001.jpg","type":"GRAPHIC","id":"NTFILEHhovYRsg9LEffxbX","market":"us","size":30513},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226004792/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEAwYVAUrL2HmEuJ8f","market":"us","size":5706}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2026-02-02 13:00","pubTimestamp":1770008400,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20613322","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226000834-PPCB","pdf_url":"","pub_time":1767762000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"PPCB","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226000834/0001493152-26-000834-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315226000834/form8-k.htm","primary":true,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILE2VXuTg1EGNQwJ99q","market":"us","size":40900}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-07 13:00","pubTimestamp":1767762000,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","summary_zh":"第3.01项:除牌通知或未能符合持续上市规则或标准;转让上市","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20586942","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315225029472-PPCB","pdf_url":"","pub_time":1767056728000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"PPCB","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1517681/0001493152-25-029472-index.html","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225029472/forms-1.htm","primary":true,"translateUrl":"","linkName":"forms-1.htm","type":"S-1","id":"NTFILECrU1WPALWkwsj2Ep","market":"us","size":5061149},{"description":"EX-5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225029472/ex5-1.htm","primary":false,"translateUrl":"","linkName":"ex5-1.htm","type":"EX-5.1","id":"NTFILEHe7QpWoE9NzNNLat","market":"us","size":18505},{"description":"EX-23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225029472/ex23-1.htm","primary":false,"translateUrl":"","linkName":"ex23-1.htm","type":"EX-23.1","id":"NTFILEGNmC5pGWYXkBkmQ2","market":"us","size":3810},{"description":"EX-FILING FEES","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225029472/ex107.htm","primary":false,"translateUrl":"","linkName":"ex107.htm","type":"EX-FILING FEES","id":"NTFILEGBG8Pf6YeZvDMo7S","market":"us","size":31083},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225029472/forms-1_001.jpg","primary":false,"translateUrl":"","linkName":"forms-1_001.jpg","type":"GRAPHIC","id":"NTFILEBTaTuYnitjzmTfWk","market":"us","size":9004},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225029472/audit_001.jpg","primary":false,"translateUrl":"","linkName":"audit_001.jpg","type":"GRAPHIC","id":"NTFILEGmJZCzBBffH5t244","market":"us","size":30462},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225029472/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEJ3Qpr6oNT6ixpsUr","market":"us","size":6201}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-12-30 09:05","pubTimestamp":1767056728,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20412289","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315225023213-PPCB","pdf_url":"","pub_time":1763096400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"PPCB","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225023213/0001493152-25-023213-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225023213/form10-q.htm","primary":true,"translateUrl":"","linkName":"form10-q.htm","type":"10-Q","id":"NTFILEDH3BFAUJQRc58YzP","market":"us","size":1605047},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225023213/ex31-1.htm","primary":false,"translateUrl":"","linkName":"ex31-1.htm","type":"EX-31.1","id":"NTFILE3sYVSRNjQCZNTyp9","market":"us","size":16594},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225023213/ex31-2.htm","primary":false,"translateUrl":"","linkName":"ex31-2.htm","type":"EX-31.2","id":"NTFILEDTygijP89QyUtcGp","market":"us","size":17124},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225023213/ex32-1.htm","primary":false,"translateUrl":"","linkName":"ex32-1.htm","type":"EX-32.1","id":"NTFILEAJk5jxMmg4LBvf2r","market":"us","size":7327},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225023213/ex32-2.htm","primary":false,"translateUrl":"","linkName":"ex32-2.htm","type":"EX-32.2","id":"NTFILE5K3NvUPUWr15WsKi","market":"us","size":7536}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-14 13:00","pubTimestamp":1763096400,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20391000","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315225021567-PPCB","pdf_url":"","pub_time":1762750800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"PPCB","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/0001493152-25-021567-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-4.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/ex4-1.htm","primary":true,"translateUrl":"","linkName":"ex4-1.htm","type":"EX-4.1","id":"NTFILE4B5Um76v1WAmxpMe","market":"us","size":304507},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILE63vGF9MQH1oVqECz","market":"us","size":41266},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/ex4-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex4-1_001.jpg","type":"GRAPHIC","id":"NTFILEGDvYLPLwJtmR3xfX","market":"us","size":32479}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-10 13:00","pubTimestamp":1762750800,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第3.02项:未经登记的股本证券销售;第5.03项:公司章程或章程的修订;财政年度的变化;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20265255","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315225018054-PPCB","pdf_url":"","pub_time":1760414400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"PPCB","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225018054/0001493152-25-018054-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-10.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225018054/ex10-1.htm","primary":true,"translateUrl":"","linkName":"ex10-1.htm","type":"EX-10.1","id":"NTFILEEvd8NDScEfxV3xNF","market":"us","size":368644},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225018054/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILEPNUrZtxuJFpsbXxd","market":"us","size":38644},{"description":"EX-10.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225018054/ex10-2.htm","primary":false,"translateUrl":"","linkName":"ex10-2.htm","type":"EX-10.2","id":"NTFILEC9hPrP1XVBJHWhgm","market":"us","size":102303}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-10-14 12:00","pubTimestamp":1760414400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项:签订重大最终协议;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.propanc.com","stockEarnings":[{"period":"1week","weight":-0.0336},{"period":"1month","weight":-0.2044},{"period":"3month","weight":-0.5077},{"period":"6month","weight":-0.8992},{"period":"1year","weight":-0.9861},{"period":"ytd","weight":-0.8927}],"compareEarnings":[{"period":"1week","weight":0.0171},{"period":"1month","weight":-0.0168},{"period":"3month","weight":0.1371},{"period":"6month","weight":0.0916},{"period":"1year","weight":0.2074},{"period":"ytd","weight":0.0936}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Propanc Biopharma, Inc.最初于2007年10月15日在澳大利亚维多利亚州墨尔本成立。2010年11月23日,该公司在特拉华州重新注册并重新注册。他们是一家发展阶段的医疗保健公司,目前专注于为患有胰腺癌、卵巢癌和癌症的患者开发新的癌症治疗方法。利用他们的科学和肿瘤学顾问,他们开发了一种合理的抗癌化合物复合配方,这些化合物共同发挥多种作用,旨在控制或防止肿瘤在体内复发和扩散。他们的主要候选产品PRP是他们新配方的变体,涉及酶原,即酶的无活性前体。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.35863},{"month":2,"riseRate":0,"avgChangeRate":-0.3412},{"month":3,"riseRate":0,"avgChangeRate":-0.231595},{"month":4,"riseRate":0,"avgChangeRate":-0.393912},{"month":5,"riseRate":0.25,"avgChangeRate":-0.125956},{"month":6,"riseRate":0.5,"avgChangeRate":0.512759},{"month":7,"riseRate":0.2,"avgChangeRate":-0.023925},{"month":8,"riseRate":0,"avgChangeRate":-0.482224},{"month":9,"riseRate":0,"avgChangeRate":-0.414214},{"month":10,"riseRate":0,"avgChangeRate":-0.267792},{"month":11,"riseRate":0,"avgChangeRate":-0.325477},{"month":12,"riseRate":0.25,"avgChangeRate":-0.177784}],"exchange":"NASDAQ","name":"Propanc Biopharma, Inc.","nameEN":"Propanc Biopharma, Inc."},"aProfile":null}}}